News
New Biomarker Classifications May Improve Treatment for High-Risk Breast Cancer Patients
Research scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients. The new cancer response subtypes reflect responsiveness to drug treatments and are intended to
E-Cigarette Use Costs U.S. $15B Per Year, Reports UCSF in First Study of Its Kind
Use of electronic cigarettes costs the United States $15 billion annually in health care expenditures – more than $2,000 per person a year – according to a study by researchers at the UC San Francisco School of Nursing. The study, published on May 23, 2022, in Tobacco Control, is the first to look
Natalia Jura Delivers 2022 Byers Award Lecture on Beating Cancer Through Molecular Photography
Natalia Jura, PhD, imagines the molecules she studies as dancers. “They have to come together for the magic to happen,” she explained during this year’s Byers Award Lecture in Basic Science, which she delivered on May 2. "Natalia Jura embodies our commitment to advancing scientific knowledge for the
Navigating From the Genome to the Clinic Using ‘Cell Maps’
Breast cancer, COVID-19, and autism may seem unrelated, but they share some surprising connections. Some of the same genes that are mutated in breast cancer also get hijacked by COVID-19, and some other genes mutated in cancer are also implicated in autism. Commonalities like these have led Nevan
